Antidepressants Market Forecast

Datamonitor
October 13, 2009
SKU: DFMN2470102
License type:
Table of Contents Related Reports
Introduction

With current blockbuster brands facing generic competition, Datamonitor forecasts the antidepressant market to decline at a compound annual growth rate of -2.0% (20082018). However, an antidepressant with a novel mechanism of action has huge commercial potential and the most promising candidate to date is Servier and Novartis's melatonin agonist and serotonin antagonist Valdoxan (agomelatine).

Reasons to Purchase
  • Quantify the current (2008) and future (2009-2018) size of the antidepressant drug class market.
  • Assess the impact of recent and anticipated events (patent expiries and new product launches) on the antidepressant drug class market.
  • Understand the country-specific impact of key events in the antidepressant drug class market during the forecast period 2009 to 2018.
Please note: this is delivered as a Zip file.


 

Share this report


Other tasks

 
 

Research Assistance

Ask a question
 

Related Markets


Behavioral Health Reports

 
 

Free Alert Me service

Receive bi-weekly email alerts on new market research

Sign Up Today!